PharmExec
JULY 10, 2023
Join five industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.
Fierce Pharma
JULY 11, 2023
Caught in a litigation crossfire, Moderna has reportedly opened two new fronts in its COVID-19 vaccine patent war with Pfizer and BioNTech. | Moderna has lodged two new lawsuits at the High Court in Dublin, Ireland, and the Brussels Commercial Court in Belgium, Juve Patent first reported. This adds to a complex web of ongoing mRNA patent litigation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JULY 11, 2023
There are three key areas of the healthcare sector where generative AI is booming the most — in terms of both venture capital funding and the development of innovative technology — according to Anjalika Komatireddy, an analyst at CB Insights. During a recent webinar, she discussed the generative AI activity occurring in these three areas: care delivery and navigation, digital therapeutics and drug discovery.
Pharmaceutical Commerce
JULY 11, 2023
The National Alliance of Healthcare Purchaser Coalitions releases resources for employers/health plan purchasers to offer insights on PBMs role in high prescription drug costs.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Copyright Clearance Center
JULY 13, 2023
After introducing The State of Scholarly Metadata: 2023 interactive report this April at the London Book Fair, we have continued to facilitate conversations about the importance of quality metadata with those in scholarly communications.
Fierce Pharma
JULY 10, 2023
Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbust | Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbuster products.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
JULY 13, 2023
In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The CDMO’s Carrie Mason shared that PAT, “takes a little bit more time and more effort and more capital to set up in the beginning, but once you get it up and running it’s very continuous and it should continue to provide results for a long time”.
PM360
JULY 13, 2023
PM360 asked six CEOs at companies developing cancer treatments to provide an update on the latest and most exciting breakthroughs in their respective areas of expertise including: antibody-drug conjugates, CAR-T immunotherapies, cytokine-based therapy, mRNA/epigenetics, precision immuno-oncology, and small molecules. Dan O’Connor Most Exciting Development Within Your Area of Cancer Treatments The most exciting development within the antibody-drug conjugate (ADC) space is site-specific conjugatio
Fierce Pharma
JULY 10, 2023
Just days after sewing up a pair of $897 million deals with Pfizer, Samsung Biologics has added a few hundred million dollars more to its partnership cash pile—this time courtesy of an expanded pac | Samsung Biologics said in a Monday regulatory filing that it’s inked a $390.9 million deal to help crank out Novartis drugs. The latest production pact builds on an earlier tie-up worth $81 million.
Pharma Marketing Network
JULY 13, 2023
When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Both have their own advantages and disadvantages, so it’s important to choose the right option for your needs. Boosting a post is a quick and easy way to get more exposure for your content. When you boost a post, you’re essentially paying to increase its reach and visibility.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
JULY 14, 2023
A report by Research and Markets has shown that at 35 percent, Europe has the largest share of the global aseptic fill finish services market at present. At 68 percent, the small molecules sector currently holds the largest share in the overall market. This trend is unlikely to change during the forecast period, the authors noted. Since there is a growing demand for pharmaceutical and biopharmaceutical drug products, a higher capacity for production of therapies is required, alongside their corr
PM360
JULY 13, 2023
“Drugs don’t work in patients who don’t take them,” C. Everett Koop, MD, U.S. Surgeon General, said in 1985. Novartis’ analysis of claims data from Nov. 2020 to Oct. 2021 revealed that roughly one in four prescriptions were never filled. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. 1 Patients may discontinue if they cannot afford their out-of-pocket costs even with insurance coverage due to side effects or lack of perc
Fierce Pharma
JULY 12, 2023
As another SGLT2 diabetes drug hits the market, the obvious question is: How will it find a way to compete against formidable blockbusters Farxiga and Jardiance? | TheracosBio and Mark Cuban's online distributor Cost Plus Drug Company have partnered to provide newly approved SGLT2 inhibitor Brenzavvy at a major discount to competitors in the class, including AstraZeneca's Farxiga and Eli Lilly and Boehringer Ingelheim's Jardiance.
Clarivate
JULY 12, 2023
Clarivate provides researchers with a more holistic and comprehensive view of the scholarly landscape within a single platform with the integration of discovery of dissertation and thesis metadata records sourced from ProQuest Dissertations & Theses Global In an era where access to reliable and comprehensive research materials is crucial, Clarivate has taken a significant step towards enhancing the research experience.
European Pharmaceutical Review
JULY 13, 2023
The field of immunotherapy is constantly evolving with the ultimate goal to develop new treatments that help the body’s immune system fight cancer. Immune cells, such as T cells and natural killer (NK) cells, have the inherent ability to combat diseases, including cancer, but are often inhibited by the body’s own suppressive mechanisms. Cancer immunotherapies such as checkpoint inhibitors (CPIs) were designed to counteract these.
Pharma Marketing Network
JULY 13, 2023
Facebook ads come in a variety of formats, each with its own strengths and weaknesses. The best format for your ad will depend on your goals and your target audience. Here is a brief overview of the most popular Facebook ad formats: ● Single image ad: This is a simple and effective format that can be used to promote a product, service, or event. The image should be high-quality and eye-catching, and the text should be clear and concise. ● Video ad: Videos are a great way to tell a story or show
Fierce Pharma
JULY 13, 2023
With the multiple sclerosis market growing rapidly—from $18.9 billion in 2020 to a projec | A phase 3 study has shown that a new, subcutaneous version of Roche's Ocrevus has proven to be non-inferior to the current infused treatment as measured by the level of drug in the blood, 12 weeks after administration. An approval for the injected version would allow patients to receive treatment in 10 minutes as opposed to four hours, every six months.
PM360
JULY 13, 2023
A 2019 study published in the Journal of Medical Internet Research mHealth and uHealth found 704 apps related to medication adherence available from Apple (443) and Android (261). And that was four years ago! I imagine anyone willing to count the apps available today would find even more. And yet, the issue of medication nonadherence persists to this day—but it is clearly not for a lack of trying.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
European Pharmaceutical Review
JULY 12, 2023
Integrated safety analysis from five prospective clinical trials for the first and only single-dose, US Food and Drug Administration (FDA)-approved microbiome -based treatment to prevent recurrent Clostridioides difficile ( C. diff ) infection after antibiotic treatment, has been published in Therapeutic Advances in Gastroenterology. The analysis is the largest safety evaluation to date of any microbiota-based live biotherapeutic.
Pharma Marketing Network
JULY 12, 2023
Social media platforms can be a great way for pharmaceutical companies to connect with their target audience and promote their products or services. However, there are some important factors to consider before deciding whether or not social media is right for your business. Here are some things to think about: ● Your target audience: Who are you trying to reach with your social media marketing?
Fierce Pharma
JULY 12, 2023
Merck is bringing more heat in its battle against drug price negotiation provisions in the Inflation Reduction Act (IRA), filing Tuesday in federal court in Washington, D.C. | Merck is bringing more heat in its battle against drug price negotiation provisions in the Inflation Reduction Act (IRA), filing Tuesday for a decision without a trial. In its request for a summary judgment, Merck reiterated its claim that the drug price negotiation program violates the First and Fifth Amendments of the Co
PM360
JULY 13, 2023
During the COVID-19 pandemic, we saw healthcare organizations spend and scramble to implement numerous virtual care point solutions. The global healthcare IT market was valued at $280.3 billion in 2020 and is expected to reach $381.7 billion by 2025, growing at a compound annual growth rate of 6.7%. 1 This increased technology spending has led to industry fragmentation, creating siloed data—which can leave providers with an incomplete picture of a patient’s health record—and an often-cumbersome
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
European Pharmaceutical Review
JULY 12, 2023
The first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis in Africa, has been prequalified by the World Health Organization (WHO). MenFive ® has been developed through a 13-year collaboration between the world’s largest vaccine manufacturer Serum Institute of India Pvt. Ltd. (SIIPL) and PATH, with funding from the UK government.
Pharma Marketing Network
JULY 12, 2023
The internet is a vast resource of information on health and wellness. However, not all of this information is created equal. Some of it is accurate and reliable, while other information may be misleading or even harmful. This is especially true when it comes to pharmaceutical-sponsored health information. Pharmaceutical companies have a vested interest in promoting their products, so it’s important to be critical of any information they put out.
Fierce Pharma
JULY 14, 2023
As Johnson & Johnson awaits a decision on its second attempt to resolve talc lawsuits through a bankruptcy ploy, the company is attempting another legal tactic to free itself from those liabili | As Johnson & Johnson awaits a decision on its second attempt to resolve talc lawsuits through a bankruptcy ploy, the company is attempting another legal tactic to help free itself from those liabilities—suing doctors who say that its iconic baby powder can cause cancer.
PM360
JULY 13, 2023
PM360 asked experts in helping patients stay on their prescribed therapies about where the industry could make the biggest improvements and how to better detect potential barriers. Specifically, we asked them: What is the biggest area where the industry could stand to improve its approach to boosting adherence? Why is the industry currently doing poorly in this area?
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
European Pharmaceutical Review
JULY 12, 2023
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the global trade body for the biopharmaceutical industry , has announced its new CEO leadership team for the next two years. Who is joining IFPMA’s new CEO leadership team? CEOS from three Big Pharma companies: Pfizer, Roche and Daiichi Sankyo will join IFPMA’s team. The C-suite lineup includes Albert Bourla, Chairman and CEO of Pfizer.
PharmExec
JULY 10, 2023
Artificial intelligence is steadily becoming a game changer for the pharma industry, particularly in commercialization activities, such as sales and marketing—and efforts to help highly sought treatments reach the right patients.
Fierce Pharma
JULY 13, 2023
After a full FDA approval last week triggered Medicare coverage of Eisai and Biogen’s Leqembi, doctors are still trying to work out the logistics of testing and reimbursement. | After a full FDA approval last week triggered Medicare coverage of Eisai and Biogen’s Leqembi, doctors are still working out the logistics of testing and reimbursement. But at least two experts remain positive about the drug’s efficacy and safety profile.
PM360
JULY 13, 2023
The media planning landscape in the pharmaceutical industry has significantly changed over the last few decades, especially since the pandemic. Pharmaceutical companies are faced with the ongoing challenge of maximizing efficiency and ROI while maintaining a strong focus on quality research and development. Although marketers have many options to manage their media planning and buying, the right model and mix are key for the ongoing success of brand marketing.
Expert insights. Personalized for you.
119 
Let's personalize your content